Medfinder
Back to blog

Updated: January 27, 2026

Entrectinib Drug Interactions: What to Avoid and What to Tell Your Doctor

Author

Peter Daggett

Peter Daggett

Two medication bottles with caution symbol showing drug interactions

Entrectinib (Rozlytrek) has serious interactions with CYP3A inhibitors, inducers, and QT-prolonging drugs. Here's what to avoid and what to tell your oncologist.

Entrectinib (Rozlytrek) interacts with a significant number of other medications, including common drugs for infections, heart conditions, seizures, and HIV. Understanding these interactions is critical for your safety. Here is a comprehensive guide to the key drug interactions you need to know about — and what to tell your oncologist and pharmacist.

How Entrectinib Is Metabolized (The CYP3A4 Connection)

Entrectinib is primarily metabolized (broken down) in the liver by an enzyme called CYP3A4 (cytochrome P450 3A4). This means that any drug that strongly affects CYP3A4 activity will also affect entrectinib blood levels — potentially causing serious side effects (if levels go too high) or reducing the drug's effectiveness (if levels go too low).

Category 1: Strong and Moderate CYP3A Inhibitors — AVOID

These drugs block CYP3A4, causing entrectinib blood levels to rise dramatically. For example, the antifungal drug itraconazole (a strong CYP3A inhibitor) increased entrectinib levels by 6-fold in clinical studies — a dangerous increase that can worsen side effects significantly. Moderate CYP3A inhibitors are predicted to increase entrectinib levels by approximately 3-fold.

Examples of strong CYP3A inhibitors to avoid with entrectinib:

Azole antifungals: itraconazole, ketoconazole, voriconazole, posaconazole

HIV protease inhibitors: ritonavir, atazanavir, lopinavir/ritonavir, nelfinavir

Macrolide antibiotics: clarithromycin (Biaxin)

Grapefruit and grapefruit juice (contains CYP3A inhibitors)

Examples of moderate CYP3A inhibitors to avoid or use with caution:

Fluconazole (common antifungal)

Erythromycin (antibiotic)

Aprepitant (anti-nausea medication used in chemotherapy)

Diltiazem and verapamil (heart medications)

Category 2: Strong and Moderate CYP3A Inducers — AVOID

These drugs speed up CYP3A4 activity, causing entrectinib to be broken down too quickly and blood levels to fall. For example, rifampin reduced entrectinib levels by 77% in clinical studies — meaning the drug may no longer be effective if taken with strong inducers.

Strong and moderate CYP3A inducers to avoid:

Rifampin, rifabutin (antibiotics/anti-tuberculosis drugs)

Phenytoin, carbamazepine, phenobarbital (anti-seizure medications)

St. John's Wort (herbal supplement — often overlooked but clinically significant)

Apalutamide (prostate cancer drug)

Armodafinil, modafinil (wakefulness agents)

Category 3: QT-Prolonging Drugs — AVOID or USE WITH CAUTION

Entrectinib itself can prolong the QT interval on an EKG — a measure of the heart's electrical cycle. When combined with other QT-prolonging drugs, the risk of a dangerous heart rhythm abnormality called Torsade de Pointes increases. Drugs in this category that commonly interact with entrectinib include:

Amiodarone (heart rhythm drug)

Ondansetron (Zofran) — commonly prescribed for nausea in cancer patients

Levofloxacin, azithromycin (antibiotics)

Adagrasib (another targeted cancer therapy)

Haloperidol and many other antipsychotics

Category 4: Drugs That Entrectinib Affects

Entrectinib can also affect the blood levels of other drugs by mildly inhibiting CYP3A4 and the P-glycoprotein (P-gp) transporter. This increases levels of:

Midazolam (sedative): entrectinib increases midazolam levels by approximately 50%

Digoxin (heart medication): entrectinib increases digoxin peak levels by ~28%

Lomitapide (cholesterol medication): dose adjustment may be needed

What to Tell Your Oncologist and Pharmacist

Before starting entrectinib, give your oncologist and specialty pharmacist a complete, up-to-date list of ALL medications, supplements, vitamins, and herbal products you take. Don't forget:

Over-the-counter medications (antacids, antihistamines, pain relievers)

Herbal supplements (especially St. John's Wort)

Any vitamins or nutritional supplements

Prescription drugs from other doctors (cardiologist, psychiatrist, neurologist, etc.)

The Bottom Line

Entrectinib has serious interactions with many common medications. The safest approach is to be completely transparent with your entire care team about everything you take. For more on managing side effects during treatment, see our guide to entrectinib side effects. And if you need help finding a pharmacy that can fill your prescription, medfinder is here to help.

Frequently Asked Questions

Avoid strong and moderate CYP3A inhibitors (e.g., itraconazole, ketoconazole, ritonavir, clarithromycin), strong and moderate CYP3A inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort), and QT-prolonging drugs (e.g., amiodarone, ondansetron/Zofran, levofloxacin). Always give your full medication list to your oncologist and pharmacist.

It depends on the antibiotic. Clarithromycin (a CYP3A inhibitor) and certain fluoroquinolones like levofloxacin (which prolongs QT) are potentially dangerous with entrectinib. Many other antibiotics are safe. Always ask your oncologist or specialty pharmacist before starting any new antibiotic while on Rozlytrek.

Some anti-nausea drugs, particularly ondansetron (Zofran), can prolong the QT interval and should be used with caution alongside entrectinib. Discuss anti-nausea management with your oncologist, who can prescribe alternatives with a lower QT-prolongation risk.

Yes, significantly. St. John's Wort is a strong CYP3A inducer that can reduce entrectinib blood levels by up to 77%, potentially making the drug ineffective. Avoid all St. John's Wort products during treatment with Rozlytrek. This includes herbal teas and supplements containing it.

Grapefruit contains natural CYP3A inhibitors that increase entrectinib blood levels, raising the risk of toxicity and side effects. Avoid all grapefruit products — including juice, fresh fruit, and any foods containing grapefruit extract — throughout your entire course of entrectinib treatment.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Entrectinib also looked for:

Larotrectinib (Vitrakvi)Repotrectinib (Augtyro)Crizotinib (Xalkori)Taletrectinib (Ibtrozi)

35,931 have already found their meds with Medfinder.

Start your search today.

35K+
5-star ratingTrusted by 35,931 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?